[LXRX] QoQ Quarter Result on 31-Mar-2020 [#Q1]

Stock
[LXRX] Lexicon Pharmaceuticals, Inc.
Announcement Date
27-Apr-2020
Financial Year
2020
Quarter
31-Mar-2020 [#Q1]
Profit Trend
QoQ- -30.26%
YoY- -205.60%
Quarter Report
LXRX's Result
LXRX's Financial Summary
View:
Show?
Quarter Result
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
Revenue 199 6,634 9,163 7,999 8,727 294,448 9,682 -92.40%
PBT -5,495 82,603 -69,071 -66,611 -51,138 220,072 -23,018 -61.34%
Tax -174 4,118 5,125 958 335 -6,014 -219 -14.15%
NP -5,495 82,603 -69,071 -66,611 -51,138 226,086 -23,018 -61.34%
Tax Rate - -4.99% - - - 2.73% - -
Total Cost 5,694 -75,969 78,234 74,610 59,865 68,362 32,700 -68.65%
Ratio Analysis
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
NP Margin -2,761.31 1,245.15 -753.80 -832.74 -585.97 76.78 -237.74 409.07%
Per Share
31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 CAGR
EPS -0.04 0.77 -0.65 -0.63 -0.48 2.13 -0.22 -67.73%
EPS Diluted -0.04 0.71 -0.65 -0.63 -0.48 1.95 -0.22 -67.73%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.